Clinical Trials Browser

Phase 2 × Withdrawn × Positron Emission Tomography Computed Tomography × Clear all

NCT04467281 2022-07-01

A Study of PET/CT Scans With the Radioactive Tracer 89Zr-DFO-Daratumumab in People With Myeloma

Phase 2 Withdrawn

Multiple Myeloma